logo-loader
RNS
Cello Health PLC

Cello Health PLC - Total Voting Rights

RNS Number : 0551Y
Cello Health PLC
16 August 2018
 

16 August 2018

 

 

Cello Health plc

 

Total Voting Rights

 

In conformity with the FCA's Disclosure Guidance and Transparency Rules, Cello Health plc ("Cello" or the "Company") confirms the following:

 

As at 16 August 2018, Cello's issued share capital consists of 105,164,241 ordinary shares of 10 pence each ("Ordinary Shares"). The Company holds 453,000 Ordinary Shares in treasury. The total number of current voting rights in the Company is therefore 104,711,241 Ordinary Shares.

 

The above figure (104,711,241 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

 

Cello Health plc

020 7812 8460

 

Mark Scott, Chief Executive

 

 

Mark Bentley, Finance Director

 

 

 

 

 

Cenkos Securities (Nomad)

0207 397 8900

 

Mark Connelly / Harry Hargreaves

 

 

 

Buchanan Communications

0207 466 5000

 

Mark Court

Jamie Hooper

Sophie Wills

 

 

 

About Cello Health plc

 

Cello Health plc is a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. Cello Health plc currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.

 

Cello Health plc enables clients to commercialise and differentiate their assets and drive brand success in ever more complex global markets. The business delivers its services through nearly 1,000 highly skilled professionals, utilising latest thinking, technology and digital solutions.

 

Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York City, Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.

 

For further information, please visit: https://cellohealthplc.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRLQLFFVVFXBBL
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read